Roche Holding AG

Annual Report

Report overview

The report describes Roche's 2019 performance across Pharmaceuticals and Diagnostics, including CHF 61,466 million in Group sales, 97,735 FTE employees and 37 million patients treated. It highlights a global materiality assessment covering 19 topics, access-to-healthcare programmes, and environmental performance including 24.1% sustainable energy share and a 29.0% eco-balance improvement since 2014. Roche also reproduces PwC assurance over selected people, SHE, contributions, payments and donations data, with both reasonable and limited assurance levels.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language
Pages
File size

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Energy consumption
Water consumption
Employees
Workplace fatalities

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services